You are here: Industry Insights > inhalation

News List

Recipharm Invests in Inhalation Development Services contractpharma
December 12, 2019
Recipharm has invested $450,000 into its Research Triangle Park (RTP), NC facility to install a SprayVIEW system that will support inhalation and nasal product development.
Lupin launches Budesonide Inhalation Suspension expressbpd
May 30, 2019
Lupin’s Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules is a generic version of AstraZeneca Pharmaceuticals LP’s Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL
Recipharm Launches Inhalation Offering contractpharma
May 16, 2019
Offers fully integrated service from early stage development through to commercial manufacturing for MDIs, DPIs, and nasal sprays.
Lupin appoints Christine Mundkur as Independent Director expressbpd
April 03, 2019
She most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc
Recipharm to buy Sanofi inhalation contract business and plant in U.K. for $60M fiercepharma
June 14, 2018
Recipharm has struck a deal with Sanofi to buy the French drugmaker’s contract inhalation drug business and plant in the U.K., picking up new capabilities and clients in the process.
Spiriva Respimat inhalation spray improves breathing for people with asthma regardless of BMI or all cphi-online
May 25, 2017
In all analyses, people experiencing uncontrolled asthma symptoms saw improvements in their breathing by adding Spiriva Respimat to an ICS or combination ICS/LABA.